LabGenomics Co., Ltd. engages in the research and development of biotechnology products in South Korea. It is also involved in the sale of diagnostic devices. The company was founded in 2002 and is based in Seongnam-si, South Korea.
Frequently asked questions
What sector does LabGenomics Co. Ltd (084650) operate in?
LabGenomics Co. Ltd belongs to the Healthcare sector and operates in the Healthcare Providers & Services industry.
What is LabGenomics Co. Ltd (084650) current stock price?
As of the latest data, LabGenomics Co. Ltd stock price is ₩1,769, with a previous close of ₩1,700. LabGenomics Co. Ltd gained ₩69 in the last trading session, representing a 4.06% increase.
What is LabGenomics Co. Ltd (084650) current market capitalization?
LabGenomics Co. Ltd market cap is approximately 16.06 billion.
What is LabGenomics Co. Ltd (084650) EBITDA?
LabGenomics Co. Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 461.83 million.
Does LabGenomics Co. Ltd (084650) pay dividends?
No. LabGenomics Co. Ltd does not pay a dividend.
What is LabGenomics Co. Ltd (084650) beta (volatility) score?
LabGenomics Co. Ltd has a beta of -0.726, indicating lower volatility than the overall market.